Literature DB >> 23102479

Endocrine and metabolic changes during sepsis: an update.

Romesh Khardori1, Danielle Castillo.   

Abstract

The authors have reviewed the most recent and relevant literature from which reasonable conclusions may be drawn. This article highlights important endocrine and metabolic changes, and provides possible explanations for observed perturbations. Obviously infectious disease specialists are not charged with the primary responsibility of addressing these issues, which have largely remained the domain of endocrinologists and intensivists. However, infectious disease specialists use a variety of drugs that can contribute to these abnormalities. Therefore, a constant dialogue between specialists would enhance the quality of care and also contribute immensely to favorable outcomes.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102479     DOI: 10.1016/j.mcna.2012.09.005

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  7 in total

Review 1.  Endocrine dysfunction in sepsis: a beneficial or deleterious host response?

Authors:  Valeriu Gheorghiţă; Alina Elena Barbu; Monica Livia Gheorghiu; Florin Alexandru Căruntu
Journal:  Germs       Date:  2015-03-02

Review 2.  Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis.

Authors:  Joshua A Englert; Angela J Rogers
Journal:  Clin Chest Med       Date:  2016-03-12       Impact factor: 2.878

3.  Metabolic Profiling of Children Undergoing Surgery for Congenital Heart Disease.

Authors:  Goncalo D S Correia; Keng Wooi Ng; Anisha Wijeyesekera; Sandra Gala-Peralta; Rachel Williams; S MacCarthy-Morrogh; Beatriz Jiménez; David Inwald; Duncan Macrae; Gary Frost; Elaine Holmes; Nazima Pathan
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

Review 4.  The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3.

Authors:  Renyu Ding; Yulan Meng; Xiaochun Ma
Journal:  Biomed Res Int       Date:  2018-06-07       Impact factor: 3.411

5.  Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial.

Authors:  Yansha Song; Xiaocen Wang; Cuicui Chen; Tingting Wei; Ke Lang; Dong Yang; Yuanlin Song
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

6.  Role of AMPK α in skeletal muscle glycometabolism regulation and adaptation in relation to sepsis.

Authors:  Xia Zheng; Mi Xu; Qiang Fang
Journal:  Biomed Res Int       Date:  2014-06-29       Impact factor: 3.411

7.  N-3 Polyunsaturated Fatty Acids Improve Liver Lipid Oxidation-Related Enzyme Levels and Increased the Peroxisome Proliferator-Activated Receptor α Expression Level in Mice Subjected to Hemorrhagic Shock/Resuscitation.

Authors:  Li Zhang; Feng Tian; Xuejin Gao; Xinying Wang; Chao Wu; Ning Li; Jieshou Li
Journal:  Nutrients       Date:  2016-04-22       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.